<DOC>
	<DOCNO>NCT00755183</DOCNO>
	<brief_summary>The objective study assess safety efficacy testosterone 0.03 % ophthalmic solution compare vehicle treatment meibomian gland dysfunction .</brief_summary>
	<brief_title>Safety Efficacy Study Testosterone Eye Drop Treatment Meibomian Gland Dysfunction</brief_title>
	<detailed_description>Meibomian gland secretion play crucial role health ocular surface function tear film . The lipid secreted meibomian gland many crucial role : 1 ) retard evaporation preocular surface ; 2 ) low surface tension tear ; 3 ) prevent spill-over tear lid margin ; 4 ) prevent contamination tear film sebaceous lipid ; 5 ) prevent damage skin lid margin . In dry eye syndrome , blepharitis , meibomian gland dysfunction , meibomitis gland central pathophysiology disease thus potential target therapy .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Inclusion Criteria ( subject must ) : Be ≥ 60 year age Have correct visual acuity LogMAR +0.5 ( ETDRS ) Have document history Meibomian Gland Dysfunction Have TFBUT ≤ 5 second Have ocular discomfort score ≥ 1 Have IOP ≤ 25 mmHg Visit 1 eye Report use and/or desire use artificial tear Exclusion Criteria ( subject may ) : Have contraindication use study medication Have know allergy sensitivity study medication Have ocular infection , active ocular inflammation Have use ocular medication within 24 hour prior Visit 1 Be current contact lens wearer Require use ophthalmic medication , tear substitute study medication provide , duration trial Have use systemic topical antihistamine steroid 48 hour prior Visit 1 require use systemic topical antihistamine steroid course study Have history prostate cancer</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Meibomian Gland Dysfunction</keyword>
	<keyword>Dry Eye Syndrome</keyword>
</DOC>